O
ISSUER//CIK 0001720725
Oyster Point Pharma, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A62.2 KBOyster Point Pharma, Inc.Feb 14, 4:59 PM ET·0001104659-23-021891
- SC 13G/A50.4 KBOyster Point Pharma, Inc.Feb 14, 4:08 PM ET·0000899140-23-000375
- SC 13G/A61.7 KBOyster Point Pharma, Inc.Feb 14, 10:05 AM ET·0000902664-23-001714
- 8-K/A226.7 KBOyster Point Pharma, Inc.Jan 13, 5:06 PM ET·0001193125-23-008477
- SC 13D/A158.9 KBOyster Point Pharma, Inc.Jan 13, 4:09 PM ET·0001193125-23-008356
- SC 13D/A98.6 KBOyster Point Pharma, Inc.Jan 9, 4:32 PM ET·0001072613-23-000017
- SC 13D/A77.8 KBOyster Point Pharma, Inc.Jan 5, 4:32 PM ET·0001193125-23-002454
- 8-K321.9 KBOyster Point Pharma, Inc.Jan 3, 9:12 AM ET·0001193125-23-000324
- SC 13D/A81.4 KBOyster Point Pharma, Inc.Dec 20, 5:41 PM ET·0001193125-22-309236
- SC 13D/A459.9 KBOyster Point Pharma, Inc.Nov 21, 1:29 PM ET·0001072613-22-000647
Insiders
10Tickers
No tickers on record
Addresses
business
202 CARNEGIE CENTER SUITE 106
PRINCETON, NJ, 08540
mailing
202 CARNEGIE CENTER SUITE 106
PRINCETON, NJ, 08540